Skip over main navigation
  • Log in
  • Basket: (0 items)
Solving Kids' Cancer
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
Shop Contact us Donate
Menu
  • About us
    • What we do
    • Meet the team
      • Trustees
      • Our team
    • Patron
    • Parent Involvement Forum
    • Join our Team
    • Annual reports
  • About neuroblastoma
    • What is neuroblastoma?
    • Symptoms
    • Diagnosis
    • Neuroblastoma treatment
  • Support
    • Family support
    • Access treatment
    • Neuroblastoma Parent Education Conference
      • Neuroblastoma Parent Global Symposium 2020
      • See past conferences
    • Other sources of help
  • Research
    • Our research
    • Scientific Advisory Board
    • Funding award process
    • Projects
    • Funding partners
    • Research policies
    • Research blog
  • Support Our Work
    • Donate now
    • Shop
    • Ambassador Programme
    • Corporate partnerships
    • Challenge events
    • Set up a fundraising page
    • Fundraising resources
  • Children’s stories
    • Stories
    • Children’s campaigns
    • In memory
    • Named funds
  • News
    • News
    • Blogs
  • Admin
    • Log in
  • Basket: (0 items)

Research policies

Solving Kids' Cancer supports clear Association of Medical Research Charities (AMRC) policies on research in universities and animal research.

Research in universities

Several of the projects we fund have been developed and are overseen by leading universities in the UK and abroad.

We are committed to ensuring the most promising academic research can be transitioned quickly and effectively from these institutions to the clinic for the benefit of children with neuroblastoma. Charities play a key role in making this possible as funding for this type of work is extremely limited, and without help from charities like Solving Kids’ Cancer many medical breakthroughs would not have been made.

For this reason, we support the AMRC position statement on supporting research in universities.

Animal research

While we do not routinely fund research using animals as part of our Research Strategy, we do support the AMRC position statement on the use of animals in research.

Published: 7th May, 2019

Updated: 26th October, 2020

Author:

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Ellie-May’s cutting 10 inches

    Ellie-May’s cutting 10 inches

    Chloe was diagnosed with high-risk neuroblastoma at just 2 years old. Chloe is now 10 years old and in February 2020 her parents were given the devastating news that she had relapsed for the second time with her disease progressing in February 2021. Let’s help Chloe fight this even by donating £1 can help!

  • Poppy's Campaign

    Poppy's Campaign

    Poppy was diagnosed with high-risk neuroblastoma at just four years old. Her family are fundraising for further treatment, either to get their daughter into remission or to try and keep the cancer away if her frontline treatment does go to plan.

  • ShinadeMiami support ting Chloe

    ShinadeMiami support ting Chloe

    It would be such a blessing to help support Chloe cause. Help Chloe which another chance with life.

  • Lily’s Big Bridge Walk with Mia scooting behind her

    Lily’s Big Bridge Walk with Mia scooting behind her

    Lily and Mia are raising money for their brave cousin Chloe Balloqui who needs cancer treatment abroad.

Most read

  • Lily-Mae, Ireland’s Tiny Dancer, supports Solving Kids’ Cancer

    Lily-Mae, Ireland’s Tiny Dancer, supports Solving Kids’ Cancer

    Lily-Mae from Galway, Ireland will be celebrating her 12th birthday this April, but for her parents Judith and Leighton every day is a blessing.

  • Corey is thriving after neuroblastoma battle

    Corey is thriving after neuroblastoma battle

    Family donate almost £150,000 to neuroblastoma research

  • Solving Kids' Cancer welcomes Alexandra Lane to the Board of Trustees

    Solving Kids' Cancer welcomes Alexandra Lane to the Board of Trustees

    Alexandra Lane was formally voted on and welcomed to our Board of Trustees this week. We are thrilled to welcome Alex to the team.

  • BEACON study opens in Europe

    BEACON study opens in Europe

    The much-anticipated BEACON study amendment is now open and recruiting patients.

  • Steve Richards to step down as Chief Executive

    Steve Richards to step down as Chief Executive

    CEO to leave Solving Kids' Cancer after three years in the role.

  • Chloe’s Journey

    Chloe’s Journey

    Chloe was diagnosed with high-risk neuroblastoma at just 2 years old. Chloe is now 10 years old and in February 2020 her parents were given the devastating news that she had relapsed for the second time with her disease progressing in February 2021.

  • Solving Kids’ Cancer appoints new Chief Executive Officer

    Solving Kids’ Cancer appoints new Chief Executive Officer

    Solving Kids’ Cancer, a national neuroblastoma charity, has appointed Gail Jackson as its new Chief Executive Officer.

  • Charities fund new clinical trial

    Charities fund new clinical trial

    Solving Kids’ Cancer, with Neuroblastoma UK, has awarded a grant of £609,762.40 to enable the SIOPEN High-Risk Neuroblastoma Clinical Trial 2 (HR-NBL2) to open in the UK, it is anticipated to open in early 2021.

  • Exploring the Statistics Behind Neuroblastoma in the UK

    Exploring the Statistics Behind Neuroblastoma in the UK

    A closer look into the National Cancer Registration and Analysis Service (NCRAS) 2021 report on cancer in children, teenagers and young adults.

  • First Three Months

    First Three Months

    Gail Jackson, CEO, launches her blog. Reflecting on personal resilience, our work and joining Solving Kids' Cancer as COVID hit.

Sign up for our newsletter

Please enter your first name
Please enter your last name
Please enter your email address Please enter a valid email address (e.g. [email protected])

Contact us

Solving Kids' Cancer UK
Coram Campus
41 Brunswick Square
London
WC1N 1AZ

Phone: 020 7284 0800

Follow us

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn

  • Jobs
  • Media enquiries
  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Safeguarding Statement
  • Privacy Policy

Solving Kids’ Cancer UK is a registered charity in England and Wales (1135601), and in Scotland (SCO45094). It is a company limited by guarantee in England and Wales (7208648). The charity and company is currently operating as Solving Kids’ Cancer.